Sign in
4

Changes in Ownership

ProQR Therapeutics N.V. Filed Acc 0001104659-26-089780

Chief Executive Officer bought 200,000 shares at $1.77 ($353,960)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
de Boer Daniel Anton Chief Executive Officer 2026-07-31 Purchase +200,000 $1.77 $353,960 500,000 D
Open-market purchases · 200,000 sh · avg $1.77 · $353,960
Loading xslF345X06/tm2622051-1_4seq1.xml…